CLL International Prognostic Index

The CLL International Prognostic Index (CLL-IPI) is a tool used by doctors to predict how a person with chronic lymphocytic leukemia (CLL) might respond to treatment and how the disease may progress. It considers factors like the patient's age, the stage of the disease, certain blood test results, and specific genetic markers. By evaluating these factors together, doctors can better assess the severity of the disease, tailor treatment plans, and provide a more accurate outlook for the patient, helping them understand their specific situation and options.